Evidence map›Paper›PMID 36253773›Full record

ArticleBMC medicine2022

Characterization of data-driven clusters in diabetes-free adults and their utility for risk stratification of type 2 diabetes.

Diego Yacamán Méndez, Minhao Zhou, Ylva Trolle Lagerros, Donaji V Gómez Velasco, Per Tynelius, Hrafnhildur Gudjonsdottir, Antonio Ponce de Leon, Katarina Eeg-Olofsson, Claes-Göran Östenson, Boel Brynedal and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Prediabetes Subgroups, Type 2 Diabetes Risk, and Differential Effects of Preventive Interventions.The Journal of clinical endocrinology and metabolism · 2025 · on this map
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Diego Yacamán MéndezDepartment of Global Public Health, Karolinska Institutet, SE-171 77, Stockholm, Sweden. diego.yacaman.mendez@ki.se.ORCID 0000-0002-8130-0229
Minhao ZhouCenter for Epidemiology and Community Medicine (CES), Stockholm Health Care Services, Stockholm, Sweden.
Ylva Trolle LagerrosObesity Center, Academic Specialist Center, Stockholm Health Care Services, Stockholm, Sweden.
Donaji V Gómez VelascoUnidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
Per TyneliusDepartment of Global Public Health, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Hrafnhildur GudjonsdottirDepartment of Global Public Health, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Antonio Ponce de LeonCenter for Epidemiology and Community Medicine (CES), Stockholm Health Care Services, Stockholm, Sweden.
Katarina Eeg-OlofssonDepartment of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Claes-Göran ÖstensonDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Boel BrynedalDepartment of Global Public Health, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Carlos A Aguilar SalinasUnidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
David EbbeviDepartment of Global Public Health, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Anton LagerDepartment of Global Public Health, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Karolinska Institutet · SEInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXStockholm Health Care Services · SEUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevention of type 2 diabetes is challenging due to the variable effects of risk factors at an individual level. Data-driven methods could be useful to detect more homogeneous groups based on risk factor variability. The aim of this study was to derive characteristic phenotypes using cluster analysis of common risk factors and to assess their utility to stratify the risk of type 2 diabetes.

methodsData on 7317 diabetes-free adults from Sweden were used in the main analysis and on 2332 diabetes-free adults from Mexico for external validation. Clusters were based on sex, family history of diabetes, educational attainment, fasting blood glucose and insulin levels, estimated insulin resistance and β-cell function, systolic and diastolic blood pressure, and BMI. The risk of type 2 diabetes was assessed using Cox proportional hazards models. The predictive accuracy and long-term stability of the clusters were then compared to different definitions of prediabetes.

resultsSix risk phenotypes were identified independently in both cohorts: very low-risk (VLR), low-risk low β-cell function (LRLB), low-risk high β-cell function (LRHB), high-risk high blood pressure (HRHBP), high-risk β-cell failure (HRBF), and high-risk insulin-resistant (HRIR). Compared to the LRHB cluster, the VLR and LRLB clusters showed a lower risk, while the HRHBP, HRBF, and HRIR clusters showed a higher risk of developing type 2 diabetes. The high-risk clusters, as a group, had a better predictive accuracy than prediabetes and adequate stability after 20 years.

conclusionsPhenotypes derived using cluster analysis were useful in stratifying the risk of type 2 diabetes among diabetes-free adults in two independent cohorts. These results could be used to develop more precise public health interventions.

Indexed as

Diabetes Mellitus, Type 2Prediabetic StateBlood GlucoseHumansInsulinRisk AssessmentRisk FactorsBlood GlucoseInsulinData-driven analysisEpidemiologyPrecision medicinePreventionPublic healthType 2 diabetes

Identifiers

PMID36253773
PMCPMC9578256
OpenAlexW4306648744

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.